Assessing the Efficacy of Indocyanine Green for Ureter Identification During Robot-Assisted Surgery in Advanced-Stage Endometriosis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

March 15, 2026

Conditions
Indocyanine Green (ICG)Robotic Surgical ProcedureDeep Infiltrating Endometriosis (DIE)Endometriosis PelvicEndometriosis (Diagnosis)Endometriosis of the Cul-de-sacUreteral Stent PlacementUreteral InjuryEndometriosis Ovaries
Interventions
DRUG

Indocyanine Green (ICG)-Assisted Ureteral Identification

A temporary ureteral stent will be placed unilaterally (left or right) prior to robotic procedures in participants undergoing robot-assisted single-site surgery for advanced-stage endometriosis. Indocyanine green (ICG) will be administered through the stent to enable real-time fluorescence imaging for intraoperative ureter identification. The contralateral ureter will be identified using standard visualization techniques without ICG. Side allocation (ICG vs. control) will be determined by computer-generated block randomization.

PROCEDURE

Standard Ureteral Identification without ICG

Ureter identification will be performed using standard intraoperative visualization techniques without the use of indocyanine green (ICG) fluorescence imaging. This will be done on the contralateral side to the randomized ICG-assisted ureteral identification during robot-assisted single-site surgery for advanced-stage endometriosis.

Trial Locations (1)

77030

Texas Childrens Hospital Pavilion for Women, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER